U.S. market Closed. Opens in 2 days 2 hours 36 minutes

BBIO | BridgeBio Pharma, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
Revenue9.30M77.65M69.72M8.25M40.56MN/AN/A
Cost of Revenue2.45M3.43M3.11M3.09M2.50MN/AN/A
Gross Profit6.86M74.21M66.60M5.16M38.06MN/AN/A
Operating Expenses606.30M546.09M646.35M482.73M304.30M183.66M43.86M
Selling, General & Admin150.59M143.19M192.21M145.68M94.35M43.59M13.30M
Research & Development455.71M402.90M454.14M337.05M209.95M140.07M30.56M
Other Operating Expenses270.00K100.45M35.82M1.63M-1.21M-1.29MN/A
Operating Income-607.37M-471.87M-579.75M-474.48M-266.24M-183.66M-43.86M
Other Expenses / Income9.44M-12.78M-6.71M-31.01M-22.34M14.75M26.00K
Before Tax Income-653.25M-484.65M-586.45M-505.49M-288.58M-169.45M-43.83M
Income Tax Expenses71.51M9.31M52.84M-21.56M-28.15M16.76MN/A
Net Income-643.20M-493.96M-639.30M-483.93M-260.44M-130.75M-30.57M
Interest Expenses81.29M80.44M46.78M36.66M8.77M2.55M13.00K
Basic Shares Outstanding162.79M147.47M144.36M118.00M105.10M92.33M92.33M
Diluted Shares Outstanding162.79M147.47M144.36M118.00M105.10M92.33M92.33M
EBITDA-574.64M-353.68M-539.68M-468.83M-279.40M-182.98M-30.29M
EBITDA Margin-6,176.95%-455.49%-774.11%-5,683.51%-688.87%0.00%0.00%
EBIT-490.40M-404.21M-539.68M-468.83M-279.82M-111.45M-30.55M
EBIT Margin-5,271.45%-520.57%-774.11%-5,683.51%-689.89%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-312018-12-312017-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙